IRF5 and Burkitt lymphoma: Hypomethylation of CpG islands in the interferon regulatory factor 5 (IRF-5) promoter was observed in EBV type III latent infected Burkitt’s lymphoma and gastric carcinoma cell lines to restrain IFR5 expression [57].